<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Triplet pregnancy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Triplet pregnancy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Triplet pregnancy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward J Hayes, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lynn L Simpson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 10, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3037921599"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Triplets and other higher order multiple gestations are associated with significantly increased risks of maternal and neonatal morbidity compared with twin and singleton gestations. The increased neonatal risks are primarily related to iatrogenic or spontaneous preterm birth: two thirds of triplet pregnancies in the United States deliver before 34 weeks compared with one-fifth of twin pregnancies and 2 percent of singleton pregnancies [<a href="#rid1">1</a>].</p><p>This topic will discuss the potential complications associated with triplet gestations and obstetric management of these pregnancies.</p><p class="headingAnchor" id="H2523667283"><span class="h1">PRIMARY PREVENTION OF TRIPLETS AND HIGHER ORDER PREGNANCIES</span><span class="headingEndMark"> — </span>The ideal outcome of assisted reproductive technology is the birth of a single, healthy neonate. Progress toward this goal has been made as a result of improvements in ovulation induction, embryo evaluation, and patient selection, including limiting the number of embryos transferred based on maternal age and embryo quality/availability for cryopreservation. Strategies to reduce the occurrence of triplets and higher order multiple births are reviewed in detail separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7417.html" rel="external">"Strategies to control the rate of high order multiple gestation"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6743.html" rel="external">"Multifetal pregnancy reduction and selective termination"</a>.)</p><p></p><p class="headingAnchor" id="H3972913897"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>In areas where medically assisted conception (ie, assisted reproductive technology [ART]) is widely available, the rate of triplet and higher order multiple births is higher than the naturally occurring rate. ART, particularly in vitro fertilization (IVF) and controlled ovarian hyperstimulation with gonadotropins, account for almost 80 percent of triplet and higher order multiple births [<a href="#rid2">2</a>]. Triplet and higher order multiple births accounted for 78.9 per 100,000 births in the United States in 2022 [<a href="#rid3">3</a>] but only 32.3 per 100,000 births in 1977 (before IVF) [<a href="#rid4">4</a>]. However, the 2022 rate of triplet births was down approximately 60 percent from the 1998 peak (193.5 per 100,000 births) and was the lowest rate in three decades as a result of transfer of fewer embryos and an increase in fetal reduction procedures. (See  <a class="medical medical_review" href="/d/html/6788.html" rel="external">"Assisted reproductive technology: Pregnancy and maternal outcomes", section on 'Multiple gestation incidence and risks'</a> and  <a class="medical medical_review" href="/d/html/7417.html" rel="external">"Strategies to control the rate of high order multiple gestation"</a> and  <a class="medical medical_review" href="/d/html/6743.html" rel="external">"Multifetal pregnancy reduction and selective termination"</a>.)</p><p class="headingAnchor" id="H1824009101"><span class="h1">CLINICAL PRESENTATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>Diagnosis of triplet pregnancy is based on ultrasound examination, which is generally initially performed for assessment of gestational age or fetal cardiac activity. An increased likelihood of triplet pregnancy may be suspected based on use of assisted reproductive technology to conceive and/or uterine size that is large for dates.</p><p class="headingAnchor" id="H1680476383"><span class="h1">COUNSELING</span><span class="headingEndMark"> — </span>Pregnant people with triplet pregnancies should be counseled about the following issues.</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal, fetal, and neonatal risks are increased in these pregnancies. Potential risks (eg, preterm birth, preeclampsia, fetal growth discordance) and their management should be discussed. Consultation with a maternal-fetal medicine specialist can be helpful. (See <a class="local">'Potential complications'</a> below and <a class="local">'Perinatal mortality and morbidity'</a> below.)</p><p></p><p class="bulletIndent1">Underlying maternal medical conditions that are exacerbated by the physiological changes of the pregnant state are more severely impacted by carrying a triplet gestation. For example, in a study of five triplet pregnancies, maternal median peak cardiac output was 8.44 L/min and occurred at 32 to 36 weeks [<a href="#rid5">5</a>], whereas the mean maternal peak cardiac output in singleton pregnancies is 6.1 L/min at the same gestational age [<a href="#rid6">6</a>]. Thus, triplet pregnancy can be a severe challenge and even life-threatening for pregnant people with some cardiac abnormalities (eg, cardiomyopathy, mitral stenosis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multifetal reduction decreases the likelihood of spontaneous preterm birth and other obstetrical and neonatal complications. In a meta-analysis of observational studies, pregnancy reduction from triplets to twins was associated with reductions in pregnancy loss, birth before 36 weeks, cesarean birth, low birth weight infants, and neonatal deaths compared with expectant management, and the rates were similar to those in spontaneously conceived twin pregnancies [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/6743.html" rel="external">"Multifetal pregnancy reduction and selective termination"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The pregnancy will need close maternal and fetal surveillance, including frequent ultrasound examinations to monitor fetal growth and well-being and frequent office visits, particularly after 20 weeks of gestation, due to the increased risk for maternal complications. (See <a class="local">'Ultrasound examination'</a> below and <a class="local">'Office visits'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antenatal hospitalization because of pregnancy complications is common. There is a high probability of cesarean birth since vaginal birth of triplets is generally avoided. (See <a class="local">'Delivery'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Carrying a triplet pregnancy and caring for triplet offspring can be physically demanding. There are also potential psychosocial and financial impacts of caring for triplets [<a href="#rid8">8,9</a>]. Connecting the patient to local groups of triplet parents can be useful, especially near the time of birth and postpartum. These groups can provide support and practical information.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The advisability of planning birth at a hospital with an on-site level III neonatal intensive care unit should be discussed, given the likelihood of preterm birth. (See  <a class="medical medical_review" href="/d/html/4998.html" rel="external">"Neonatal complications of multiple births"</a>.)</p><p></p><p>Many other issues are the same as in any pregnancy. (See  <a class="medical medical_review" href="/d/html/446.html" rel="external">"Prenatal care: Initial assessment"</a> and  <a class="medical medical_review" href="/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters"</a> and  <a class="medical medical_review" href="/d/html/112420.html" rel="external">"Prenatal care: Patient education, health promotion, and safety of commonly used drugs"</a>.)</p><p class="headingAnchor" id="H3126415161"><span class="h1">BASIC ANTEPARTUM CARE</span></p><p class="headingAnchor" id="H2586557571"><span class="h2">Ultrasound examination</span><span class="headingEndMark"> — </span>Frequent ultrasound examination is essential for monitoring triplet pregnancies. Standard office procedures for monitoring growth and viability of singleton pregnancies, such as measuring the fundal height and listening to the fetal heart rate, are not as effective for detecting problems in triplets. Ultrasound is also the only means for monitoring triplets for complications, such as congenital anomalies and twin-twin transfusion.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment of gestational age</strong> – In individuals who became pregnant as a result of an assisted reproductive technique, ultrasound examination of the pregnancy is generally first performed at six weeks of gestation, which is when the fetal heartbeat may first be detected. Online calculators (eg, the pregnancy due date and gestational age calculator [<a href="#rid10">10</a>]) and apps are available for calculating the estimated date of delivery and gestational age based on one of the following dates, as appropriate: date of ovulation, date of egg retrieval, date of insemination, or date of cleavage stage (day 3) or blastocyst (day 5) transfer. (See  <a class="medical medical_review" href="/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight", section on 'Assigning an estimated date of delivery to pregnancies conceived by assisted reproduction'</a>.)</p><p></p><p class="bulletIndent1">In naturally conceived triplet pregnancies, assessment of gestational age and determination of the estimated date of delivery is the same as for singletons. (See  <a class="medical medical_review" href="/d/html/5391.html" rel="external">"Prenatal assessment of gestational age, date of delivery, and fetal weight"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Determining chorioamnionicity</strong> – Determination of chorionicity and amnionicity, which is ideally performed between 8 and 13 weeks of gestation, is critical for risk assessment, counseling, and pregnancy management. For example, a dichorionic triamniotic triplet pregnancy is at risk for twin-twin transfusion syndrome (TTTS) and twin-anemia polycythemia sequence (TAPS), which worsen the perinatal prognosis; however, close fetal monitoring for these conditions and therapeutic intervention can improve outcome [<a href="#rid11">11,12</a>]. The procedure for and interpretation of chorioamnionicity is similar to that in twin pregnancies. (See  <a class="medical medical_review" href="/d/html/6821.html" rel="external">"Twin pregnancy: Overview", section on 'Assessment of chorionicity and amnionicity'</a> and  <a class="medical medical_review" href="/d/html/6789.html" rel="external">"Twin-twin transfusion syndrome: Screening, prevalence, pathophysiology, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/130852.html" rel="external">"Twin anemia-polycythemia sequence (TAPS)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screening for congenital anomalies</strong> – The initial first-trimester ultrasound examination may detect abnormalities potentially associated with an adverse outcome. These include congenital anomalies, crown-rump length discordance (which can be associated with aneuploidy or TTTS), and enlarged nuchal translucency (NT; which can be associated with aneuploidy, some congenital anomalies, or TTTS). (See  <a class="medical medical_review" href="/d/html/410.html" rel="external">"Diagnosis and outcome of first-trimester growth delay"</a> and  <a class="medical medical_review" href="/d/html/435.html" rel="external">"Enlarged nuchal translucency and cystic hygroma"</a>.)</p><p></p><p class="bulletIndent1">At approximately 20 weeks of gestation, we perform a detailed ultrasound examination to survey the fetal anatomy in all triplet pregnancies. The examination is more challenging than in singletons because three fetuses need to be examined, a clear anatomic survey of each fetus can be difficult to obtain and may require a repeat examination, and any anomalies that are identified need to be associated with the correct fetus.</p><p></p><p class="bulletIndent1">Structural abnormalities, particularly cardiac abnormalities, are more common in triplet pregnancies, mainly because of the higher incidence of abnormalities in monozygotic siblings (owing to the cleavage of the conceptus) compared with dizygotic siblings. Anomalies are generally discordant among the triplets, so management needs to consider both issues specific to the anomalous triplet(s) and the effects of the anomalies and their management on the nonanomalous triplet(s). (See  <a class="medical medical_review" href="/d/html/130561.html" rel="external">"Twin pregnancy: Routine prenatal care", section on 'Screening for congenital anomalies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Labeling the triplets</strong> – It is important to use a consistent strategy for identifying and labeling each triplet over serial ultrasound examinations in the second and third trimesters. Each triplet may be identified based on its sex and orientation relative to the other triplets, although the orientation can change. Documentation of the sites of placental implantation (anterior, posterior, lateral) and the sites and types of placental cord insertion (eg, marginal versus central; normal versus velamentous) is also useful for labeling. Triplets may not deliver in the order expected from antenatal ultrasound (termed perinatal switch), especially when delivered by cesarean.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Second- and third-trimester ultrasound monitoring</strong> – We base the timing and frequency of second- and third-trimester ultrasound examinations on chorionicity and amnionicity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Monochorionic triamniotic and dichorionic triamniotic triplets </strong>– Any multiple gestation with a shared chorionic sac  (<a class="graphic graphic_figure graphicRef120560" href="/d/graphic/120560.html" rel="external">figure 1</a>) places the involved fetuses at risk for TTTS, selective growth restriction, and TAPS. We follow an ultrasound protocol similar to that commonly used for monitoring monochorionic twin pregnancies  (<a class="graphic graphic_table graphicRef118804" href="/d/graphic/118804.html" rel="external">table 1</a>) [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/6789.html" rel="external">"Twin-twin transfusion syndrome: Screening, prevalence, pathophysiology, and diagnosis", section on 'Our approach to monitoring'</a> and  <a class="medical medical_review" href="/d/html/120803.html" rel="external">"Selective fetal growth restriction in monochorionic twin pregnancies"</a>.)</p><p></p><p class="bulletIndent2">In a series of 152 monochorionic triamniotic triplet pregnancies, TTTS was the most common antenatal complication related to chorionicity and occurred in 27.6 percent of these pregnancies [<a href="#rid14">14</a>]. Selective fetal growth restriction was the second most common antenatal complication related to chorionicity and occurred in 16.4 percent. TAPS occurred in 4.6 percent.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Monochorionic monoamniotic or dichorionic diamniotic triplets </strong>– Any multiple gestation with a shared amniotic sac (monoamniotic component)  (<a class="graphic graphic_figure graphicRef120562" href="/d/graphic/120562.html" rel="external">figure 2</a>) places the involved fetuses at high risk of cord entanglement and death from cord compression. Experts suggest admitting patients with this type of placentation to the hospital at 26 weeks of gestation to facilitate performance of one hour of continuous fetal heart rate monitoring every eight hours. (See <a class="local">'Cord entanglement in monoamniotic multiples'</a> below.)</p><p></p><p class="bulletIndent2">We suggest not using Doppler velocimetry of umbilical cord vessels for routine monitoring of monoamniotic twins to detect altered flow suggestive of cord entanglement and compression [<a href="#rid15">15</a>]. Although high blood velocity in the umbilical vein [<a href="#rid16">16,17</a>], a notch in the umbilical artery waveform [<a href="#rid18">18</a>], or persistent absent end-diastolic flow [<a href="#rid19">19</a>] may suggest compromise of the fetoplacental circulation, these findings have poor specificity.</p><p></p><p class="bulletIndent2">Multiple gestations with a shared amniotic sac are also at risk for TTTS, selective growth restriction, and TAPS. Ultrasound monitoring for these conditions is the same as that described above for triplets with a shared chorionic sac (monochorionic triamniotic and dichorionic triamniotic triplets).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Trichorionic triamniotic triplets </strong>– Trichorionic triamniotic placentation  (<a class="graphic graphic_figure graphicRef120563" href="/d/graphic/120563.html" rel="external">figure 3</a>) is associated with more favorable perinatal outcomes than triplet pregnancies in which the fetuses share an amniotic sac or placenta/chorion [<a href="#rid20">20,21</a>]. Growth restriction is still a major concern, so starting at 20 weeks, ultrasound examination is generally performed every three to four weeks to monitor fetal growth. (See  <a class="medical medical_review" href="/d/html/6768.html" rel="external">"Fetal growth restriction: Evaluation"</a>.)</p><p></p><p class="bulletIndent2">Monitoring for TTTS and TAPS is unnecessary since the placenta is not shared.</p><p></p><p class="headingAnchor" id="H3006385546"><span class="h2">Office visits</span><span class="headingEndMark"> — </span>In the first half of pregnancy, office visits can be scheduled per usual obstetric standards for singleton pregnancy. We see patients weekly beginning at 24 weeks of gestation to closely monitor for signs/symptoms of preeclampsia and preterm labor. However, there is limited evidence that weekly visits improve outcomes. Others have recommended visits at 20, 24, 28, 32, and 34 weeks for trichorionic triamniotic triplets and at 20, 22, 24, 26, 28, 30, 32, and 34 weeks for monochorionic triamniotic and dichorionic triamniotic triplets [<a href="#rid22">22</a>]. Weekly visits are appropriate from 34 weeks until birth, which is typically scheduled by 35+6 weeks. (See <a class="local">'Delivery'</a> below.)</p><p class="headingAnchor" id="H1313135450"><span class="h2">Physical and sexual activity</span><span class="headingEndMark"> — </span>There is no consensus about physical activity for pregnant people carrying triplets given a lack of definitive data. Our activity recommendations are, in general, similar to those for pregnant people with singleton gestations, especially prior to 20 weeks of gestation. (See  <a class="medical medical_review" href="/d/html/412.html" rel="external">"Exercise during pregnancy and the postpartum period"</a>.)</p><p>After approximately 20 weeks of gestation, many pregnant people with uncomplicated triplet pregnancy will want to limit physical activity because of fatigue and physical discomfort; in the mid-to-late second trimester, the uterus enlarges to a size comparable to that of a singleton at term. These individuals can rest and reduce activity in and outside of the home, as needed.</p><p>Sexual intercourse does not appear to increase the risk of preterm birth [<a href="#rid23">23</a>]; abstinence is not necessary.</p><p class="headingAnchor" id="H304515280"><span class="h2">Weight gain</span><span class="headingEndMark"> — </span>Evidenced-based weight gain and nutritional guidelines for triplet pregnancies are lacking. We use the following gestational weight gain targets, which reflect the higher end of National Academy of Medicine (formerly the Institute of Medicine [IOM]) gestational weight gain guidelines for twin pregnancies that go to term [<a href="#rid24">24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Body mass index (BMI) 18.5 to 24.9 kg/m<sup>2</sup> (normal weight) – 25 kg (54 lbs)</p><p class="bulletIndent1"><span class="glyph">●</span>BMI 25.0 to 29.9 kg/m<sup>2</sup> (overweight) – 23 kg (50 lbs)</p><p class="bulletIndent1"><span class="glyph">●</span>BMI ≥30.0 kg/m<sup>2</sup> (obese) – 19 kg (42 lbs)</p><p></p><p>However, almost no triplet pregnancies go to term. A more clinically practical recommendation is maternal weight gain of approximately 0.7 kg (1.5 lbs) per week and &gt;16.2 kg (36 lbs) by 24 weeks of gestation since weight gain below this threshold has been associated with lower birth weights in triplets [<a href="#rid25">25</a>].</p><p>Some authorities believe that these gestational weight gain targets are too high. The target described above for pregnant patients with obesity is particularly controversial. For pregnant patients with obesity and a singleton gestation, gestational weight gain lower than that recommended by the National Academy of Medicine may be associated with better maternal and perinatal outcomes, and this may also be true for pregnant patients with obesity and triplet gestations. </p><p>Gestational weight gain and loss in pregnant patients with obesity is discussed in more detail separately, but available data are from singleton pregnancies. (See  <a class="medical medical_review" href="/d/html/441.html" rel="external">"Gestational weight gain", section on 'Overweight and obese pregnant people'</a>.)</p><p class="headingAnchor" id="H261500333"><span class="h2">Micronutrients</span><span class="headingEndMark"> — </span>Our recommendations for daily micronutrient supplementation are based on existing data for twin pregnancies, as described by the Society for Maternal-Fetal Medicine  (<a class="graphic graphic_table graphicRef113748" href="/d/graphic/113748.html" rel="external">table 2</a>) [<a href="#rid26">26</a>]. One or two multivitamins or one prenatal vitamin may be consumed daily. The content of vitamins varies depending on the product selected. (See  <a class="medical medical_review" href="/d/html/453.html" rel="external">"Nutrition in pregnancy: Dietary requirements and supplements", section on 'Supplements and dietary intake that can be harmful'</a>.)</p><p class="headingAnchor" id="H858701973"><span class="h2">Preeclampsia prophylaxis</span><span class="headingEndMark"> — </span>Low-dose <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> should be initiated between 12 and 28 weeks (optimally before 16 weeks) and continued daily until delivery. (See <a class="local">'Preeclampsia'</a> below.)</p><p class="headingAnchor" id="H1210373326"><span class="h2">Aneuploidy screening and diagnosis</span><span class="headingEndMark"> — </span>We suggest offering genetic counseling to all pregnant people with triplet gestations to discuss their risk of aneuploidy in one or more fetuses. The risk of aneuploidy in a trizygotic triplet pregnancy is higher than in a singleton or dizygotic twin pregnancy since there are three independent fetal risks for aneuploidy. The pregnancy trisomy 21 risk of a 28-year-old individual carrying a trizygotic triplet pregnancy is similar to the pregnancy trisomy 21 risk of a 35-year-old individual carrying a singleton [<a href="#rid27">27</a>]. Thus, the conventional application of advanced maternal age as applied to aneuploidy risk may be considered to be a maternal age ≥28 years at the estimated date of delivery.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screening</strong> – The distribution of NT measurements is the same in triplets as it is in singletons, so NT can be used to screen for trisomy 21 and other anomalies [<a href="#rid28">28</a>]. Increased NT (defined as greater than the 95<sup>th</sup> percentile for gestational age) has been validated as a screening test for trisomy 21 and trisomy 18 in triplets based on one study [<a href="#rid29">29</a>]. In this study, five of six aneuploid fetuses had increased NT (three cases of trisomy 21, one of trisomy 18, and one of monosomy of chromosome X; a mosaic 45,X/46,XX was missed). (See  <a class="medical medical_review" href="/d/html/435.html" rel="external">"Enlarged nuchal translucency and cystic hygroma", section on 'Clinical significance'</a>.)</p><p></p><p class="bulletIndent1">No serum marker or cell-free DNA (cfDNA) screening test for aneuploidy has been validated in triplet gestations, and no study has published observed detection rates for Down syndrome and other common trisomies in triplet pregnancies. Given the rarity of triplet pregnancies and the reticence of providers to offer serum-based or cfDNA screening in this group, it is unlikely that the type of dataset now available for twins will ever be available for triplet pregnancies. However, with the limited data available and acknowledging an up to 20 percent test failure rate, the International Society for Prenatal Diagnosis (ISPD) position statement on cfDNA screening for Down syndrome in triplet gestations states cfDNA screening may be a potential option, but diagnostic testing should always be offered and the limitations of screening tests in triplet gestations should be stressed [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fetal diagnosis</strong> – Chorionic villus sampling (CVS) is one option for prenatal diagnosis of aneuploidy. This technique is particularly useful for pregnant people with high age-related risk of fetal aneuploidy who are planning multifetal pregnancy reduction. Because karyotype results generally are available prior to the reduction procedure, it is possible to identify and selectively reduce an aneuploid fetus. However, CVS is more difficult in triplet than singleton gestations, and the patient must understand that it can be difficult to be certain that all three placentas have been sampled rather than one placenta sampled twice and another missed altogether. The risk of a sampling error in triplets and higher order gestations was 1.2 percent in one study [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/449.html" rel="external">"Chorionic villus sampling", section on 'Multiple gestations'</a>.)</p><p></p><p class="bulletIndent1">Genetic amniocentesis is another option for prenatal diagnosis. The procedure-related pregnancy loss rate is probably similar to that after genetic amniocentesis in a singleton pregnancy. (See  <a class="medical medical_review" href="/d/html/5390.html" rel="external">"Diagnostic amniocentesis", section on 'Multiple gestation'</a>.)</p><p></p><p class="headingAnchor" id="H1680390758"><span class="h2">Screening for neural tube defects</span><span class="headingEndMark"> — </span>All triplets should undergo a focused anatomic survey of the neural tube in the second trimester, given that serum screening for neural tube defects with maternal serum alpha-fetoprotein has not been validated in triplets. (See  <a class="medical medical_review" href="/d/html/460.html" rel="external">"Neural tube defects: Overview of prenatal screening, evaluation, and pregnancy management", section on 'Ultrasound examination'</a>.)</p><p class="headingAnchor" id="H964544100"><span class="h2">Screening for gestational diabetes</span><span class="headingEndMark"> — </span>Since triplet pregnancies are at high risk for gestational diabetes when compared with singletons (12.8 versus 2.9 percent, respectively, in one study [<a href="#rid32">32</a>]) and a high proportion of these patients (in the author's practice) have insulin resistance related to polycystic ovary syndrome, this author agrees with others [<a href="#rid32">32</a>] who recommend screening for diabetes early in pregnancy (eg, at the first or second prenatal visit). If this screen is negative, screening is repeated at 24 to 28 weeks of gestation. </p><p>Screening tests and management of diabetes are the same as in pregnant people with singleton pregnancies and described in detail separately. (See  <a class="medical medical_review" href="/d/html/6797.html" rel="external">"Gestational diabetes mellitus: Screening, diagnosis, and prevention"</a> and  <a class="medical medical_review" href="/d/html/6790.html" rel="external">"Gestational diabetes mellitus: Glucose management and maternal prognosis"</a>.)</p><p class="headingAnchor" id="H1117333706"><span class="h2">Screening for anemia</span><span class="headingEndMark"> — </span>Assessment for anemia is performed at 24 to 28 weeks along with screening for gestational diabetes. Patients with anemia should be evaluated for the cause, which is often iron deficiency. Treatment of iron deficiency anemia in pregnancy is discussed separately. (See  <a class="medical medical_review" href="/d/html/115637.html" rel="external">"Anemia in pregnancy", section on 'Treatment of iron deficiency'</a>.)</p><p class="headingAnchor" id="H1531294474"><span class="h2">Antepartum fetal monitoring</span><span class="headingEndMark"> — </span>There are no evidence-based guidelines regarding when and how often to perform antepartum fetal monitoring in triplets (see  <a class="medical medical_review" href="/d/html/457.html" rel="external">"Overview of antepartum fetal assessment"</a>). Fetal testing is based on chorioamnionicity:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monochorionic triamniotic and dichorionic triamniotic triplets</strong> – We obtain a weekly biophysical profile score starting at 28 weeks of gestation because all of these pregnancies are at high risk for fetal complications because of the shared chorionic sac. Ultrasound allows identification of each fetus and thus avoids the technical difficulties encountered when performing nonstress tests in higher order multiples [<a href="#rid33">33</a>]. However, nonstress testing is an acceptable alternative.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monochorionic monoamniotic or dichorionic diamniotic triplets</strong> – We suggest monitoring these triplets three times daily with one hour of continuous fetal heart rate monitoring when the mother is hospitalized at approximately 26 weeks of gestation. The goal is to detect decelerations, which suggest cord entanglement with cord compression in the shared amniotic sac, and this is more readily accomplished with prolonged fetal heart rate monitoring with the biophysical profile. (See <a class="local">'Cord entanglement in monoamniotic multiples'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trichorionic triamniotic triplets</strong> – We obtain a weekly biophysical profile score beginning at 32 weeks, based on evidence that dichorionic twins are at increased risk for stillbirth with advancing gestational age [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/d/html/457.html" rel="external">"Overview of antepartum fetal assessment"</a>.)</p><p></p><p>When results of fetal monitoring of a singleton preterm fetus are nonreassuring, the decision to intervene is determined by whether the fetus's risk from remaining in utero exceeds that from preterm birth. In multiple gestations, an ethical dilemma arises when one fetus is in jeopardy but the others are not. These decisions are complex and should be made jointly with, at a minimum, the parents, a maternal-fetal medicine specialist, and a neonatologist.</p><p class="headingAnchor" id="H593829278"><span class="h2">Monitoring for preterm labor</span><span class="headingEndMark"> — </span>Preterm birth is the most common cause of death and morbidity in triplet gestations. We educate patients about the signs and symptoms of preterm labor but do not perform routine digital cervical examination, fetal fibronectin screening, or home uterine activity monitoring, as these interventions have no proven benefit on pregnancy outcome. (See <a class="local">'Risk for preterm birth'</a> below.)</p><p class="headingAnchor" id="H2321996466"><span class="h3">Role of sonographic cervical length measurement</span><span class="headingEndMark"> — </span>We do not measure cervical length in triplet pregnancies. Although this is a common screening test for prediction of preterm birth in singleton and twin pregnancies, a short cervical length was not a sensitive screening test for prediction of preterm birth in triplets in the three retrospective studies that evaluated this issue [<a href="#rid35">35-37</a>]. In all of these studies, the median cervical length was over 30 mm up to approximately 24 weeks and then declined, but no threshold was useful for prediction of preterm birth. Furthermore, in contrast to singleton and twin pregnancies, the limited data on the efficacy of any intervention (eg, <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> supplementation, cerclage) for preventing preterm birth in patients with triplets and short cervical length suggest no benefit [<a href="#rid38">38-40</a>].</p><p class="headingAnchor" id="H187486925"><span class="h1">POTENTIAL COMPLICATIONS</span></p><p class="headingAnchor" id="H2395773253"><span class="h2">Spontaneous fetal reduction</span><span class="headingEndMark"> — </span>A substantial number of triplet gestations undergo spontaneous loss of one sac in the first trimester, which is referred to as a "vanishing twin." The rate of loss correlates with the initial number of gestational sacs. In one study, spontaneous reduction of one or more gestational sacs and/or embryos occurred in 53 percent and loss of all three sacs occurred in 6 percent of 132 triplet pregnancies diagnosed before 12 weeks [<a href="#rid41">41</a>]. Most losses occurred before the ninth gestational week.</p><p>The triplet pregnancies that experienced spontaneous reduction delivered earlier than naturally occurring pregnancies with the same number of fetuses (eg, triplets-to-singletons delivered 10 days earlier than naturally occurring singletons, triplets-to-twins delivered four days earlier than naturally occurring twins) [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H2225250437"><span class="h2">Risk for preterm birth</span><span class="headingEndMark"> — </span>Preterm birth is the most common cause of death and morbidity in triplet gestations. Iatrogenic preterm birth is as common as spontaneous preterm birth in some series [<a href="#rid42">42</a>].</p><p>In 2020, 98.7 percent of triplets delivered before 37 weeks of gestation in the United States, and 65.8 percent delivered before 34 weeks of gestation [<a href="#rid43">43</a>]. Ninety-five percent of triplets were low birth weight (&lt;2500 g), and 36 percent were very low birth weight (&lt;1500 g). By comparison, 2.1 percent of singletons delivered before 34 weeks, and 1.1 percent weighed &lt;1500 g. The mean gestational age of delivery for triplets is approximately 32 weeks versus 38.7 weeks in singletons [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H561756171"><span class="h3">Potentially useful interventions</span><span class="headingEndMark"> — </span>Multiple interventions have been investigated to reduce the risk for preterm birth. None have proven efficacious; however, administration of corticosteroids and <a class="drug drug_general" data-topicid="9585" href="/d/drug information/9585.html" rel="external">magnesium sulfate</a> may reduce neonatal morbidity, as in singleton pregnancies.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antenatal corticosteroids for fetal maturation</strong> – For triplets that are not monoamniotic, we administer a course of <a class="drug drug_general" data-topicid="9139" href="/d/drug information/9139.html" rel="external">betamethasone</a> if we believe the clinical findings suggest an increased risk for birth within the next seven days since steroids are most effective within this time frame. Examples include patients who experience ruptured membranes or threatened preterm labor or who develop a maternal or fetal disorder that may require preterm birth within days. Routine universal steroid administration to triplet pregnancies is not warranted, as the overall frequency of birth within seven days was &lt;10 percent before 32 weeks in one study [<a href="#rid45">45</a>]; thus, many triplet pregnancies that received an early course of steroids would need repeated courses to ensure exposure proximate to birth.</p><p></p><p class="bulletIndent1">However, for monoamniotic triplets, we routinely administer a course of antenatal corticosteroids at 26 weeks when we admit the patient to the hospital for intensive fetal monitoring. These pregnancies are at high risk for early unexpected birth. (See  <a class="medical medical_review" href="/d/html/6766.html" rel="external">"Monoamniotic twin pregnancy (including conjoined twins)"</a>.)</p><p></p><p class="bulletIndent1">Standard <a class="drug drug_general" data-topicid="9139" href="/d/drug information/9139.html" rel="external">betamethasone</a> doses are administered; there is no convincing evidence that the dose should be increased with an increasing number of fetuses.</p><p></p><p class="bulletIndent1">We suggest a second course of antenatal corticosteroids if it has been more than a week since the prior course, the patient is at increased risk for preterm birth within the next seven days, and the pregnancy is less than 34 weeks. We do not administer steroids after 34 weeks as no data are available on efficacy in multiple gestations late in gestation. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery", section on '34+0 or more weeks'</a>.)</p><p></p><p class="bulletIndent1">The value of antenatal corticosteroid therapy is well-established in singleton pregnancies, but neonatal outcomes after in utero exposure to corticosteroids have not been examined in randomized trials of triplet gestations, and the magnitude of benefit in these pregnancies is less clear [<a href="#rid46">46-48</a>]. In the United States, the National Institutes of Health recommends administration of one course of antenatal corticosteroids (unless contraindicated) irrespective of the fetal number. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery", section on 'Multiple gestation'</a> and  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery", section on 'Evidence of efficacy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9585" href="/d/drug information/9585.html" rel="external">Magnesium sulfate</a><strong> for neuroprotection</strong> – We suggest magnesium sulfate for neuroprotection for those triplet pregnancies at risk for imminent delivery (ie, within 24 hours) between 23+0 and 31+6<sup> </sup>weeks. We use the Marret regimen (4 g magnesium sulfate bolus over 30 minutes with no continuous infusion [<a href="#rid49">49</a>]) because omitting the continuous infusion may reduce the risk for pulmonary edema, which may be more common in triplet pregnancies receiving this drug [<a href="#rid50">50</a>]. Other regimens (eg, 4 g bolus with 1 g/hour continuous infusion) can also be used. (See  <a class="medical medical_review" href="/d/html/4481.html" rel="external">"Neuroprotective effects of in utero exposure to magnesium sulfate"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Delayed interval delivery </strong>– Typically, all fetuses of a triplet gestation are born within a short interval; however, in rare selected cases, the periviable birth of one or two fetuses may not require delivery of the other fetus(es) [<a href="#rid51">51</a>]. This is termed delayed interval delivery and may improve neonatal survival and reduce morbidity from very early preterm birth. Selection of candidates for delayed interval delivery and management of these rare pregnancies are reviewed separately. (See  <a class="medical medical_review" href="/d/html/6771.html" rel="external">"Multifetal gestation: Approach to delayed-interval delivery"</a>.)</p><p></p><p class="headingAnchor" id="H2456813123"><span class="h3">Unproven interventions</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tocolytics for treatment of preterm labor</strong> – The author does not use tocolytic drugs to treat preterm contractions or preterm labor in patients with triplets. No tocolytic has been proven to improve neonatal outcomes when compared with placebo [<a href="#rid52">52-55</a>], and tocolytic use in multiple gestations results in a higher incidence of adverse events, such as pulmonary edema [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1">Others may administer a tocolytic for 48 hours to allow for administration of <a class="drug drug_general" data-topicid="9139" href="/d/drug information/9139.html" rel="external">betamethasone</a>. A calcium channel blocker or nonsteroidal anti-inflammatory drug, depending on gestational age, is the preferred tocolytic. (See  <a class="medical medical_review" href="/d/html/6742.html" rel="external">"Inhibition of acute preterm labor"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prophylactic tocolytics </strong>–<strong> </strong>There is no role for the prophylactic use of tocolytic agents in any multiple gestation, including triplets. There has been no proven reduction in the incidence of preterm birth, low birth weight, or neonatal mortality [<a href="#rid57">57</a>]. Moreover, the prolonged use of betamimetics has been linked to an increased risk of adverse maternal cardiovascular events including maternal death [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prophylactic cerclage</strong> – Prophylactic cerclage (defined as a cerclage placed only because of triplet pregnancy) in patients without a history of cervical insufficiency does not appear to prolong gestation or improve neonatal outcomes [<a href="#rid59">59</a>]. In a retrospective cohort study of over 7000 triplet deliveries in the United States with risk factors for cervical insufficiency, the cerclage and noncerclage groups had similar gestational age at delivery and risk of preterm birth at &lt;34 and &lt;32 weeks [<a href="#rid60">60</a>]. However, cerclage was associated with a higher risk of the composite outcome of neonatal complications (aOR 1.5, 95% CI 1.1-2.2).</p><p></p><p class="bulletIndent1">In small observational studies of triplet gestations with asymptomatic cervical shortening during serial sonographic surveillance of cervical length, placement of an ultrasound-indicated cerclage for cervical length &lt;25 mm did not result in any improvement in neonatal outcome compared with expectant management [<a href="#rid61">61,62</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prophylactic pessary </strong>–<strong> </strong>Use of a pessary to reduce the risk of preterm birth in triplets is not recommended. The largest randomized trial of use of prophylactic pessaries in over 800 unselected multiple gestations reported the intervention did not decrease the incidence of poor perinatal outcomes [<a href="#rid63">63</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bed rest</strong> – There is no convincing evidence that bed rest improves pregnancy outcome in triplets, and it may be harmful due to the risk for thrombosis and deconditioning. In a systematic review of six randomized trials that assessed the effectiveness of strict or partial bed rest at home or in the hospital compared with no activity restriction in patients with a multiple pregnancy (twins or triplets), the intervention did not reduce preterm birth or perinatal mortality, but the quality of evidence was low [<a href="#rid64">64</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">Progesterone</a><strong> supplementation</strong> – Progesterone supplementation is not recommended to reduce the risk of preterm birth because of absence of data showing benefit. In an individual patient data meta-analysis of three placebo-controlled randomized trials of <a class="drug drug_general" data-topicid="16452" href="/d/drug information/16452.html" rel="external">hydroxyprogesterone caproate</a> supplementation of asymptomatic patients with triplet pregnancies, supplementation did not result in a statistical reduction in preterm birth &lt;28, 32, or 34 weeks or composite adverse perinatal outcome [<a href="#rid65">65</a>]. Of note, one trial found that hydroxyprogesterone caproate resulted in a significant increase in the number of midtrimester fetal losses (13 in 56 versus 0 in 25 in the placebo group) [<a href="#rid38">38</a>]. No trials have evaluated use of vaginal progesterone to reduce the risk of preterm birth in unselected triplet gestations or in triplet gestations with short cervical length.</p><p></p><p class="headingAnchor" id="H3808649376"><span class="h2">Preeclampsia</span><span class="headingEndMark"> — </span>The frequency of preeclampsia is higher in triplet pregnancies than in singleton gestations (10 versus 3 to 5 percent) [<a href="#rid66">66</a>]. Preeclampsia occurs earlier and is more severe in multiple gestations, and HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count) is more likely [<a href="#rid67">67</a>].</p><p>The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine support the United States Preventive Services Task Force recommendation of low-dose <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> to reduce the occurrence of preeclampsia and its associated complications of preterm birth and intrauterine growth restriction in multifetal gestations [<a href="#rid68">68,69</a>]. Low-dose aspirin should be initiated between 12 and 28 weeks (optimally before 16 weeks) and continued daily until delivery. The daily dose ranges from 81 to 162 mg depending on the formulation available. (See  <a class="medical medical_review" href="/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Candidates'</a>.)</p><p class="headingAnchor" id="H3674358324"><span class="h2">Late fetal demise</span><span class="headingEndMark"> — </span>The rate of fetal demise after 22 weeks of gestation is related to chorioamnionicity; in one study, fetal demise occurred in 0.8 percent of trichorionic triplet pregnancies (12 out of 1521) versus 2.7 percent of monochorionic triamniotic triplet pregnancies (4 out of 150) [<a href="#rid20">20</a>].</p><p>Although no study has specifically examined the outcomes of survivors of co-triplet demise, this risk likely depends on whether they shared a chorionic sac with the demised triplet. For example, monochorionic survivors of a co-twin fetal demise have higher rates of subsequent demise, preterm birth, and neurodevelopmental impairment than dichorionic survivors of a co-twin fetal demise. (See  <a class="medical medical_review" href="/d/html/131147.html" rel="external">"Twin pregnancy: Management of pregnancy complications", section on 'Death of one twin'</a>.)</p><p>After demise of one or two triplets with monochorionic placentation, injury to the surviving fetus or fetuses is thought to occur instantaneously; thus, immediate delivery will not prevent adverse outcomes related to this event [<a href="#rid70">70</a>]. We base birth timing on the usual standards for the remaining twin or singleton gestation but implement fetal surveillance with weekly biophysical profiles (nonstress tests are a reasonable alternative) and serial ultrasound growth scans.</p><p class="headingAnchor" id="H2536768121"><span class="h2">Fetal growth restriction or discordant growth</span><span class="headingEndMark"> — </span>Fetal growth is monitored by ultrasound examination; initiation and frequency are guided by the type of placentation, as described above. (See <a class="local">'Ultrasound examination'</a> above.)</p><p>We diagnose fetal growth restriction by the same criteria used for singleton pregnancies (see  <a class="medical medical_review" href="/d/html/6752.html" rel="external">"Fetal growth restriction: Screening and diagnosis"</a>). Because triplet growth starts to deviate from singleton growth in the third trimester [<a href="#rid71">71-74</a>], use of these criteria may overdiagnose impaired fetal growth. For this reason, several authors have published growth tables specific for triplet pregnancies (medians, 10<sup>th</sup> and 90<sup>th</sup> percentiles) [<a href="#rid75">75-78</a>]. Whether these tables perform better for detecting fetuses at increased risk of adverse fetal/neonatal outcome is unknown.</p><p>Discordant growth of multiples is usually defined as a 20 to 25 percent difference in sonographic estimated fetal weight (EFW) of the smaller compared with the larger fetus (difference of larger minus smaller EFW divided by larger EFW). Discordance may be a marker for structural or genetic anomalies, infection, twin-twin transfusion syndrome (TTTS), or placental insufficiency.</p><p>Based on twin studies, evidence of growth restriction of one or both fetuses is a stronger predictor of adverse neonatal outcome than growth discordance alone. Management of growth restriction and growth discordance is based on the etiology. (See  <a class="medical medical_review" href="/d/html/6768.html" rel="external">"Fetal growth restriction: Evaluation"</a>.)</p><p class="headingAnchor" id="H2627727952"><span class="h2">Twin-twin transfusion</span><span class="headingEndMark"> — </span>As discussed above, triplets with shared chorions are monitored for TTTS (see <a class="local">'Ultrasound examination'</a> above). Discordant amniotic fluid volume (polyhydramnios/oligohydramnios sequence) suggests TTTS. (See  <a class="medical medical_review" href="/d/html/6789.html" rel="external">"Twin-twin transfusion syndrome: Screening, prevalence, pathophysiology, and diagnosis"</a>.)</p><p>Laser coagulation is an effective treatment, even in triplets. (See  <a class="medical medical_review" href="/d/html/6793.html" rel="external">"Twin-twin transfusion syndrome: Management and outcome", section on 'Triplet pregnancies'</a>.)</p><p class="headingAnchor" id="H1775669041"><span class="h2">Twin-anemia polycythemia sequence</span><span class="headingEndMark"> — </span>Twin-anemia polycythemia sequence (TAPS) is uncommon in triplets; few cases have been reported [<a href="#rid79">79,80</a>]. Treatment is the same as in twin pregnancies complicated by TAPS. (See  <a class="medical medical_review" href="/d/html/6793.html" rel="external">"Twin-twin transfusion syndrome: Management and outcome", section on 'Twin anemia polycythemia sequence'</a>.)</p><p class="headingAnchor" id="H1564687323"><span class="h2">Cord entanglement in monoamniotic multiples</span><span class="headingEndMark"> — </span>Monoamniotic placentation in any multiple gestation places the involved fetuses at high risk of cord entanglement and death from cord compression. (See  <a class="medical medical_review" href="/d/html/6766.html" rel="external">"Monoamniotic twin pregnancy (including conjoined twins)", section on 'Cord entanglement'</a>.)</p><p>As discussed above, to reduce this risk, we admit these patients to the hospital at 26 weeks of gestation for intensive fetal heart rate monitoring (one hour of continuous monitoring every eight hours), administer a course of antenatal corticosteroids, and deliver them by cesarean at 32 to 33 weeks of gestation. (See <a class="local">'Delivery'</a> below.)</p><p class="headingAnchor" id="H660285815"><span class="h2">Other complications</span><span class="headingEndMark"> — </span>The following pregnancy complications are also more common in triplet pregnancies than singleton pregnancies. Diagnosis and management are similar to that in singleton pregnancies with the same complication.</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea and vomiting of pregnancy. (See  <a class="medical medical_review" href="/d/html/6792.html" rel="external">"Nausea and vomiting of pregnancy: Clinical findings and evaluation"</a> and  <a class="medical medical_review" href="/d/html/6811.html" rel="external">"Nausea and vomiting of pregnancy: Treatment and outcome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Placental abruption has been reported in 1.6 percent of triplet pregnancies versus &lt;1 percent of singleton pregnancies [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/d/html/6826.html" rel="external">"Acute placental abruption: Pathophysiology, clinical features, diagnosis, and consequences"</a> and  <a class="medical medical_review" href="/d/html/6803.html" rel="external">"Acute placental abruption: Management and long-term prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thrombocytopenia occurs in up to one-third of triplet gestations. The most common cause is preeclampsia [<a href="#rid81">81</a>]. (See  <a class="medical medical_review" href="/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6825.html" rel="external">"Preeclampsia: Antepartum management and timing of delivery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute fatty liver of pregnancy has been reported in up to 7 percent of triplet pregnancies versus 1 in 10,000 singleton pregnancies [<a href="#rid82">82</a>]. (See  <a class="medical medical_review" href="/d/html/3619.html" rel="external">"Acute fatty liver of pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intrahepatic cholestasis of pregnancy is observed more commonly in multiple gestations. (See  <a class="medical medical_review" href="/d/html/3560.html" rel="external">"Intrahepatic cholestasis of pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple gestation is a risk factor for uterine atony resulting in postpartum hemorrhage, transfusion, and possibly hysterectomy. (See  <a class="medical medical_review" href="/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postpartum depression and other psychological disorders are more common after a multiple birth [<a href="#rid8">8,83,84</a>]. (See  <a class="medical medical_review" href="/d/html/1704.html" rel="external">"Postpartum unipolar major depression: Epidemiology, clinical features, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/88582.html" rel="external">"Severe postpartum unipolar major depression: Choosing treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple gestation has been associated with an increased risk for placenta previa [<a href="#rid85">85</a>], which may be related to the large placental volume in multiples and increased exposure to assisted reproductive techniques [<a href="#rid86">86</a>]. (See  <a class="medical medical_review" href="/d/html/6772.html" rel="external">"Placenta previa: Epidemiology, clinical features, diagnosis, morbidity and mortality"</a> and  <a class="medical medical_review" href="/d/html/6809.html" rel="external">"Placenta previa: Management"</a>.)</p><p></p><p class="headingAnchor" id="H4140048182"><span class="h1">DELIVERY</span></p><p class="headingAnchor" id="H3787051438"><span class="h2">Timing</span><span class="headingEndMark"> — </span>Birth timing is based on amnionicity. We suggest the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monoamniotic or diamniotic triplets</strong> – These triplets are delivered by cesarean at approximately 32+4<sup> </sup>weeks of gestation (ie, between 32+0 to 32+6 weeks) based on extrapolation of the finding that the in utero risk of fetal demise of a monoamniotic multiple gestation exceeds the risk of a postnatal nonrespiratory complication at this gestational age [<a href="#rid87">87</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Triamniotic triplets</strong> – Uncomplicated triplet pregnancies with three amniotic sacs, whether monochorionic, dichorionic, or trichorionic, are delivered between 35+0 and 35+6 weeks of gestation. Earlier delivery is indicated in complicated pregnancies; timing depends on the individual clinical scenario.</p><p></p><p class="bulletIndent1">In a review commissioned by the National Institute for Health and Clinical Excellence, the committee concluded that continuing an uncomplicated trichorionic triamniotic or a dichorionic triamniotic triplet pregnancy beyond 35+6 weeks of gestation would lead to an increased risk of fetal death, based on their clinical experience as no studies on birth timing in triplets was available [<a href="#rid88">88</a>]. </p><p></p><p class="headingAnchor" id="H4150532205"><span class="h2">Route of delivery</span><span class="headingEndMark"> — </span>Cesarean birth is the preferred route for all triplet gestations. A review of data from a national database found that vaginal birth of triplets was associated with an increased risk for stillbirth and neonatal and infant deaths as compared with cesarean birth [<a href="#rid89">89</a>]. This finding was supported by a multicenter retrospective United States cohort study that reported the rate for successful attempted vaginal birth was only 16.7 percent (four triplet sets), and vaginal birth was associated with a higher risk of maternal transfusion and neonatal mechanical ventilation, as well as a trend toward increased composite neonatal morbidity [<a href="#rid90">90</a>]. However, obstetricians experienced in vaginal birth of multiple gestations can consider offering patients planned vaginal birth of triplets using a shared decision-making approach [<a href="#rid91">91</a>]. (See  <a class="medical medical_review" href="/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery"</a> and  <a class="medical medical_review" href="/d/html/4467.html" rel="external">"Twin pregnancy: Labor and delivery", section on 'Analgesia and anesthesia'</a>.)</p><p>Multiple gestations are at increased risk for uterine atony, postpartum hemorrhage, and emergency hysterectomy [<a href="#rid92">92</a>], so preparation for these potential complications is important. (See  <a class="medical medical_review" href="/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage"</a>.)</p><p class="headingAnchor" id="H362639834"><span class="h2">Anesthesia</span><span class="headingEndMark"> — </span>Neuroaxial anesthesia is recommended (see  <a class="medical medical_review" href="/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Choice of anesthetic technique'</a>). It is particularly useful for those few patients with triplets attempting a vaginal birth, as it helps to facilitate operative delivery, external or internal version, and total breech extraction.</p><p class="headingAnchor" id="H1812137191"><span class="h1">PERINATAL MORTALITY AND MORBIDITY</span><span class="headingEndMark"> — </span>Preterm birth and low birth weight are the most common causes of death and morbidity in triplet gestations. In two population-based cohort studies, overall perinatal mortality was approximately 2.5 percent [<a href="#rid20">20,93</a>], and monochorionic triplet pregnancies had a 2.6-fold greater risk of perinatal death than trichorionic triplet pregnancies (odds ratio 2.6, 95% CI 1.17-5.76) [<a href="#rid20">20</a>]. The mean/median gestational age at birth was approximately 33 weeks of gestation in both studies, and neonatal morbidity was common, consistent with the early gestational age of these births [<a href="#rid20">20,93</a>]. (See  <a class="medical medical_review" href="/d/html/4998.html" rel="external">"Neonatal complications of multiple births"</a>.)</p><p class="headingAnchor" id="H1234200912"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/123102.html" rel="external">"Society guideline links: Multiple gestation"</a>.)</p><p class="headingAnchor" id="H3865377008"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Pregnant people with triplet pregnancies should be counseled about the specific issues and risks associated with these pregnancies, management of complications, and the recommendation for cesarean birth. Surveillance of triplet pregnancies includes more frequent ultrasound examinations and frequent office visits (discussed below), particularly after 20 weeks of gestation, due to the increased risk of maternal morbidity and perinatal morbidity and mortality. In the second half of pregnancy, these pregnancies are at increased risk for preterm birth, preeclampsia, or fetal growth discordance when compared with singletons. Many other issues are the same as in any pregnancy. (See <a class="local">'Counseling'</a> above and <a class="local">'Perinatal mortality and morbidity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gestational weight gain</strong> – We use the following gestational weight gain targets, which reflect the higher end of National Academy of Medicine gestational weight gain guidelines for twins (see <a class="local">'Weight gain'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Body mass index (BMI) 18.5 to 24.9 kg/m<sup>2</sup> (normal weight): 25 kg (54 lbs)</p><p class="bulletIndent2"><span class="glyph">•</span>BMI 25.0 to 29.9 kg/m<sup>2</sup> (overweight): 23 kg (50 lbs)</p><p class="bulletIndent2"><span class="glyph">•</span>BMI ≥30.0 kg/m<sup>2</sup> (obese): 19 kg (42 lbs)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prenatal care</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ultrasound examinations</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span>We perform an ultrasound in the first or early second trimester to ascertain if the triplet pregnancy is trichorionic, fully monochorionic, or has a monochorionic twin pair to help guide counseling and management. (See <a class="local">'Ultrasound examination'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Cervical length measurement is not a sensitive screening test for prediction of preterm birth in multiple gestations, and there is no strong evidence that any intervention (eg, <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> supplementation, cerclage) is beneficial for preventing preterm birth in patients with multiple gestation and short cervical length. (See <a class="local">'Monitoring for preterm labor'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>We suggest a focused anatomic survey in the second trimester to screen for neural tube defects rather than serum screening. (See <a class="local">'Screening for neural tube defects'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Fetal growth is monitored by ultrasound examination; initiation and frequency are guided by the type of placentation, as described above. (See <a class="local">'Ultrasound examination'</a> above.)</p><p></p><p class="bulletIndent3">We diagnose fetal growth restriction by the same criteria used for singleton pregnancies. Discordant growth of multiples is usually defined as a 20 to 25 percent difference in sonographic estimated fetal weight (EFW) of the smaller compared with the larger fetus (difference of larger minus smaller EFW divided by larger EFW). Discordance may be a marker for structural or genetic anomalies, infection, twin-twin transfusion syndrome, or placenta-mediated disease. (See <a class="local">'Fetal growth restriction or discordant growth'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Genetic counseling</strong> – We offer genetic counseling to discuss the risk of aneuploidy in one or more fetuses. No serum marker or cell-free DNA screening test for aneuploidy has been validated in this population. Increased nuchal translucency (defined as greater than the 95<sup>th</sup> percentile for gestational age) has been validated as a screening test for trisomy 21 and trisomy 18 but not for trisomy 13. (See <a class="local">'Aneuploidy screening and diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preeclampsia prophylaxis</strong> – We prescribe daily low-dose <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> after 12 weeks of gestation to reduce the occurrence of preeclampsia and its associated complications (preterm birth and growth restriction). (See <a class="local">'Preeclampsia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Screening for diabetes</strong> - We screen for diabetes at the first prenatal visit and, if negative, again at 24 weeks of gestation. (See <a class="local">'Screening for gestational diabetes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reducing newborn risks from preterm birth</strong> – Multiple interventions have been investigated to reduce the risk for preterm birth; none have proven efficacious. However, administration of corticosteroids and <a class="drug drug_general" data-topicid="9585" href="/d/drug information/9585.html" rel="external">magnesium sulfate</a> may reduce neonatal morbidity from preterm birth. (See <a class="local">'Risk for preterm birth'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing of delivery</strong> – Delivery timing is based on the type of amnionicity, irrespective of lung maturity. We deliver monoamniotic and diamniotic triplets at approximately 32+4 weeks of gestation (ie, between 32+0 and 32+6 weeks). Uncomplicated triplet pregnancies with three amniotic sacs, whether monochorionic, dichorionic, or trichorionic, are delivered between 35+0 and 35+6 weeks of gestation. Earlier delivery is indicated in complicated pregnancies; timing depends on the individual clinical scenario. (See <a class="local">'Delivery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Route of delivery</strong> – We suggest delivery by cesarean (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Route of delivery'</a> above.)</p><p></p><p class="headingAnchor" id="H1819763634"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges David C. Jones, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Osterman M, Hamilton B, Martin JA, et al. Births: Final Data for 2020. Natl Vital Stat Rep 2021; 70:1.</a></li><li><a class="nounderline abstract_t">Kulkarni AD, Jamieson DJ, Jones HW Jr, et al. Fertility treatments and multiple births in the United States. N Engl J Med 2013; 369:2218.</a></li><li><a class="nounderline abstract_t">QuickStats: Rate of Triplet and Higher-Order Multiple Births,*,† by Age of Mother - National Vital Statistics System, United States, 1998 and 2022. MMWR Morb Mortal Wkly Rep 2024; 72:1394.</a></li><li><a class="nounderline abstract_t">Martin JA, MacDorman MF, Mathews TJ. Triplet births: trends and outcomes, 1971-94. Vital Health Stat 21 1997; :1.</a></li><li><a class="nounderline abstract_t">Ladhani NN, Milligan N, Carvalho J, et al. Maternal hemodynamic changes in multiple gestation pregnancy: a longitudinal, pilot study. Am J Obstet Gynecol 2013; 209:S104.</a></li><li><a class="nounderline abstract_t">Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation 2014; 130:1003.</a></li><li><a class="nounderline abstract_t">Dodd JM, Crowther CA. Reduction of the number of fetuses for women with triplet and higher order multiple pregnancies. Cochrane Database Syst Rev 2003; :CD003932.</a></li><li><a class="nounderline abstract_t">Sheard C, Cox S, Oates M, et al. Impact of a multiple, IVF birth on post-partum mental health: a composite analysis. Hum Reprod 2007; 22:2058.</a></li><li><a class="nounderline abstract_t">Glazebrook C, Sheard C, Cox S, et al. Parenting stress in first-time mothers of twins and triplets conceived after in vitro fertilization. Fertil Steril 2004; 81:505.</a></li><li class="breakAll">Pregnancy Due Date and Gestational Age Calculator. http://perinatology.com/calculators/Due-Date.htm (Accessed on November 05, 2020).</li><li><a class="nounderline abstract_t">Lopes Perdigao J, Straub H, Zhou Y, et al. Perinatal and obstetric outcomes of dichorionic vs trichorionic triplet pregnancies. Am J Obstet Gynecol 2016; 214:659.e1.</a></li><li><a class="nounderline abstract_t">Peeva G, Chaveeva P, Gil Guevara E, et al. Endoscopic Placental Laser Coagulation in Dichorionic and Monochorionic Triplet Pregnancies. Fetal Diagn Ther 2016; 40:174.</a></li><li><a class="nounderline abstract_t">Society for Maternal-Fetal Medicine, Simpson LL. Twin-twin transfusion syndrome. Am J Obstet Gynecol 2013; 208:3.</a></li><li><a class="nounderline abstract_t">Sileo FG, Accurti V, Baschat A, et al. Perinatal outcome of monochorionic triamniotic triplet pregnancy: multicenter cohort study. Ultrasound Obstet Gynecol 2023; 62:540.</a></li><li><a class="nounderline abstract_t">Aurioles-Garibay A, Hernandez-Andrade E, Romero R, et al. Presence of an umbilical artery notch in monochorionic/monoamniotic twins. Fetal Diagn Ther 2014; 36:305.</a></li><li><a class="nounderline abstract_t">Belfort MA, Moise KJ Jr, Kirshon B, Saade G. The use of color flow Doppler ultrasonography to diagnose umbilical cord entanglement in monoamniotic twin gestations. Am J Obstet Gynecol 1993; 168:601.</a></li><li><a class="nounderline abstract_t">Gembruch U, Baschat AA. True knot of the umbilical cord: transient constrictive effect to umbilical venous blood flow demonstrated by Doppler sonography. Ultrasound Obstet Gynecol 1996; 8:53.</a></li><li><a class="nounderline abstract_t">Abuhamad AZ, Mari G, Copel JA, et al. Umbilical artery flow velocity waveforms in monoamniotic twins with cord entanglement. Obstet Gynecol 1995; 86:674.</a></li><li><a class="nounderline abstract_t">Rosemond RL, Hinds NE. Persistent abnormal umbilical cord Doppler velocimetry in a monoamniotic twin with cord entanglement. J Ultrasound Med 1998; 17:337.</a></li><li><a class="nounderline abstract_t">Kawaguchi H, Ishii K, Yamamoto R, et al. Perinatal death of triplet pregnancies by chorionicity. Am J Obstet Gynecol 2013; 209:36.e1.</a></li><li><a class="nounderline abstract_t">Peress DA, Peaceman AM, Yee LM. Evaluation of Trichorionic versus Dichorionic Triplet Gestations from 2005 to 2016 in a Large, Referral Maternity Center. Am J Perinatol 2017; 34:599.</a></li><li><a class="nounderline abstract_t">Bricker L. Optimal antenatal care for twin and triplet pregnancy: the evidence base. Best Pract Res Clin Obstet Gynaecol 2014; 28:305.</a></li><li><a class="nounderline abstract_t">Yost NP, Owen J, Berghella V, et al. Effect of coitus on recurrent preterm birth. Obstet Gynecol 2006; 107:793.</a></li><li class="breakAll">Institute of Medicine. Weight gain during pregnancy: Reexaming the guidelines. The National Academies Press; Washington, DC 2009.</li><li><a class="nounderline abstract_t">Flidel-Rimon O, Rhea DJ, Keith LG, et al. Early adequate maternal weight gain is associated with fewer small for gestational age triplets. J Perinat Med 2005; 33:379.</a></li><li><a class="nounderline abstract_t">Goodnight W, Newman R, Society of Maternal-Fetal Medicine. Optimal nutrition for improved twin pregnancy outcome. Obstet Gynecol 2009; 114:1121.</a></li><li class="breakAll">Malone FD, D’Alton ME. Multiple gestation clinical characteristics and management. In: Maternal-Fetal Medicine Principles and Practice, 5th ed, Saunders, Philadelphia 2004.</li><li><a class="nounderline abstract_t">Maslovitz S, Yaron Y, Fait G, et al. Feasibility of nuchal translucency in triplet pregnancies. J Ultrasound Med 2004; 23:501.</a></li><li><a class="nounderline abstract_t">Sepulveda W, Wong AE, Casasbuenas A. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies. Ultrasound Obstet Gynecol 2009; 33:152.</a></li><li><a class="nounderline abstract_t">Palomaki GE, Chiu RWK, Pertile MD, et al. International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies. Prenat Diagn 2021; 41:1222.</a></li><li><a class="nounderline abstract_t">Eddleman KA, Stone JL, Lynch L, Berkowitz RL. Chorionic villus sampling before multifetal pregnancy reduction. Am J Obstet Gynecol 2000; 183:1078.</a></li><li><a class="nounderline abstract_t">Weissman A, Drugan A. Glucose tolerance in singleton, twin and triplet pregnancies. J Perinat Med 2016; 44:893.</a></li><li><a class="nounderline abstract_t">Elliott JP, Finberg HJ. Biophysical profile testing as an indicator of fetal well-being in high-order multiple gestations. Am J Obstet Gynecol 1995; 172:508.</a></li><li><a class="nounderline abstract_t">Cheong-See F, Schuit E, Arroyo-Manzano D, et al. Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis. BMJ 2016; 354:i4353.</a></li><li><a class="nounderline abstract_t">Fichera A, Pagani G, Stagnati V, et al. Cervical-length measurement in mid-gestation to predict spontaneous preterm birth in asymptomatic triplet pregnancy. Ultrasound Obstet Gynecol 2018; 51:614.</a></li><li><a class="nounderline abstract_t">Pils S, Springer S, Wehrmann V, et al. Cervical length dynamics in triplet pregnancies: a retrospective cohort study. Arch Gynecol Obstet 2017; 296:191.</a></li><li><a class="nounderline abstract_t">Rosen H, Hiersch L, Freeman H, et al. The role of serial measurements of cervical length in asymptomatic women with triplet pregnancy. J Matern Fetal Neonatal Med 2018; 31:713.</a></li><li><a class="nounderline abstract_t">Combs CA, Garite T, Maurel K, et al. Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2010; 203:248.e1.</a></li><li><a class="nounderline abstract_t">Caritis SN, Rouse DJ, Peaceman AM, et al. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol 2009; 113:285.</a></li><li><a class="nounderline abstract_t">Rafael TJ, Berghella V, Alfirevic Z. Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy. Cochrane Database Syst Rev 2014; :CD009166.</a></li><li><a class="nounderline abstract_t">Dickey RP, Taylor SN, Lu PY, et al. Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. Am J Obstet Gynecol 2002; 186:77.</a></li><li><a class="nounderline abstract_t">Razavi AS, Kalish RB, Coombs S, et al. Preterm delivery in triplet pregnancies. J Matern Fetal Neonatal Med 2017; 30:2596.</a></li><li><a class="nounderline abstract_t">Osterman MJK, Hamilton BE, Martin JA, et al. Births: Final Data for 2020. Natl Vital Stat Rep 2022; 70:1.</a></li><li><a class="nounderline abstract_t">Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2009. Natl Vital Stat Rep 2011; 60:1.</a></li><li><a class="nounderline abstract_t">van de Mheen L, Ravelli AC, Oudijk MA, et al. Prediction of Time to Delivery Week-by-Week in Women with a Triplet Pregnancy. Am J Perinatol 2016; 33:1394.</a></li><li><a class="nounderline abstract_t">Blickstein I, Shinwell ES, Lusky A, et al. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol 2005; 192:360.</a></li><li><a class="nounderline abstract_t">Al-Yatama MK, Al Essa M, Omu AE, et al. Effect of repeated doses of dexamethasone on the incidence and severity of respiratory distress syndrome in multifetal gestation between 24 and 34 weeks. Gynecol Obstet Invest 2001; 52:26.</a></li><li><a class="nounderline abstract_t">Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017; 3:CD004454.</a></li><li><a class="nounderline abstract_t">Marret S, Marpeau L, Zupan-Simunek V, et al. Magnesium sulphate given before very-preterm birth to protect infant brain: The randomised controlled PREMAG trial*. BJOG 2007; 114:310.</a></li><li><a class="nounderline abstract_t">Poggi SH, Barr S, Cannum R, et al. Risk factors for pulmonary edema in triplet pregnancies. J Perinatol 2003; 23:462.</a></li><li><a class="nounderline abstract_t">Ghorbani M, Moghadam S. A Triplet Pregnancy With Spontaneous Delivery of a Fetus at Gestational Age of 20 Weeks and Pregnancy Continuation of Two Other Fetuses Until Week 33. Glob J Health Sci 2015; 8:88.</a></li><li><a class="nounderline abstract_t">Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002; :CD001060.</a></li><li><a class="nounderline abstract_t">King JF, Flenady VJ, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; :CD002255.</a></li><li><a class="nounderline abstract_t">Anotayanonth S, Subhedar NV, Garner P, et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004; :CD004352.</a></li><li><a class="nounderline abstract_t">King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005; :CD001992.</a></li><li><a class="nounderline abstract_t">Pisani RJ, Rosenow EC 3rd. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989; 110:714.</a></li><li><a class="nounderline abstract_t">Yamasmit W, Chaithongwongwatthana S, Tolosa JE, et al. Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy. Cochrane Database Syst Rev 2015; :CD004733.</a></li><li class="breakAll">FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor. US Food and Drug Administration; Silver Spring, MD 2011.</li><li><a class="nounderline abstract_t">Rebarber A, Roman AS, Istwan N, et al. Prophylactic cerclage in the management of triplet pregnancies. Am J Obstet Gynecol 2005; 193:1193.</a></li><li><a class="nounderline abstract_t">Vilchez G, Kumar K, Singh S, et al. Risk of preterm birth and neonatal outcomes after cerclage placement in triplet pregnancies. J Matern Fetal Neonatal Med 2022; 35:5409.</a></li><li><a class="nounderline abstract_t">Young CM, Stanisic T, Wynn LB, et al. Use of cerclage in triplet pregnancies with an asymptomatic short cervix. J Ultrasound Med 2014; 33:343.</a></li><li><a class="nounderline abstract_t">Moragianni VA, Cohen JD, Smith SJ, et al. The role of ultrasound-indicated cerclage in triplets. Ultrasound Obstet Gynecol 2009; 34:43.</a></li><li><a class="nounderline abstract_t">Liem S, Schuit E, Hegeman M, et al. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial. Lancet 2013; 382:1341.</a></li><li><a class="nounderline abstract_t">da Silva Lopes K, Takemoto Y, Ota E, et al. Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes. Cochrane Database Syst Rev 2017; 3:CD012031.</a></li><li><a class="nounderline abstract_t">Combs CA, Schuit E, Caritis SN, et al. 17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis. BJOG 2016; 123:682.</a></li><li><a class="nounderline abstract_t">Wen SW, Demissie K, Yang Q, Walker MC. Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order multiple pregnancies. Am J Obstet Gynecol 2004; 191:254.</a></li><li><a class="nounderline abstract_t">Day MC, Barton JR, O'Brien JM, et al. The effect of fetal number on the development of hypertensive conditions of pregnancy. Obstet Gynecol 2005; 106:927.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 326:1186.</a></li><li class="breakAll">American College of Obstetricians and Gynecologists' Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality. December 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/12/low-dose-aspirin-use-for-the-prevention-of-preeclampsia-and-related-morbidity-and-mortality (Accessed on December 21, 2021).</li><li><a class="nounderline abstract_t">Karageyim Karsidag AY, Kars B, Dansuk R, et al. Brain damage to the survivor within 30 min of co-twin demise in monochorionic twins. Fetal Diagn Ther 2005; 20:91.</a></li><li><a class="nounderline abstract_t">Alexander GR, Kogan M, Martin J, Papiernik E. What are the fetal growth patterns of singletons, twins, and triplets in the United States? Clin Obstet Gynecol 1998; 41:114.</a></li><li><a class="nounderline abstract_t">Blickstein I, Jacques DL, Keith LG. Total and individual triplet birth weights as a function of gestational age. Am J Obstet Gynecol 2002; 186:1372.</a></li><li><a class="nounderline abstract_t">Min SJ, Luke B, Min L, et al. Birth weight references for triplets. Am J Obstet Gynecol 2004; 191:809.</a></li><li><a class="nounderline abstract_t">Weissman A, Jakobi P, Yoffe N, et al. Sonographic growth measurements in triplet pregnancies. Obstet Gynecol 1990; 75:324.</a></li><li><a class="nounderline abstract_t">Rodis JF, Arky L, Egan JF, et al. Comprehensive fetal ultrasonographic growth measurements in triplet gestations. Am J Obstet Gynecol 1999; 181:1128.</a></li><li><a class="nounderline abstract_t">Vora NL, Ruthazer R, House M, Chelmow D. Triplet ultrasound growth parameters. Obstet Gynecol 2006; 107:694.</a></li><li><a class="nounderline abstract_t">Fountain SA, Morrison JJ, Smith SK, Winston RM. Ultrasonographic growth measurements in triplet pregnancies. J Perinat Med 1995; 23:257.</a></li><li><a class="nounderline abstract_t">Kuno A, Akiyama M, Yanagihara T, Hata T. Comparison of fetal growth in singleton, twin, and triplet pregnancies. Hum Reprod 1999; 14:1352.</a></li><li><a class="nounderline abstract_t">Griersmith TH, Fung AM, Walker SP. Dichorionic triamniotic triplet pregnancy complicated by twin anemia polycythemia sequence: the place of fetal therapy. Twin Res Hum Genet 2014; 17:589.</a></li><li><a class="nounderline abstract_t">Davidoff DF, Dickinson JE, Warner T, Pennell CE. Twin-twin transfusion syndrome and twin anemia-polycythemia sequence in a monochorionic triamniotic pregnancy. Twin Res Hum Genet 2013; 16:716.</a></li><li><a class="nounderline abstract_t">Al-Kouatly HB, Chasen ST, Kalish RB, Chervenak FA. Causes of thrombocytopenia in triplet gestations. Am J Obstet Gynecol 2003; 189:177.</a></li><li><a class="nounderline abstract_t">Malone FD, Kaufman GE, Chelmow D, et al. Maternal morbidity associated with triplet pregnancy. Am J Perinatol 1998; 15:73.</a></li><li><a class="nounderline abstract_t">Garel M, Salobir C, Blondel B. Psychological consequences of having triplets: a 4-year follow-up study. Fertil Steril 1997; 67:1162.</a></li><li><a class="nounderline abstract_t">Garel M, Salobir C, Lelong N, Blondel B. [Mothers of triplets and their children: course from 4 to 7 years after birth]. Gynecol Obstet Fertil 2000; 28:792.</a></li><li><a class="nounderline abstract_t">Ananth CV, Demissie K, Smulian JC, Vintzileos AM. Placenta previa in singleton and twin births in the United States, 1989 through 1998: a comparison of risk factor profiles and associated conditions. Am J Obstet Gynecol 2003; 188:275.</a></li><li><a class="nounderline abstract_t">Karami M, Jenabi E, Fereidooni B. The association of placenta previa and assisted reproductive techniques: a meta-analysis. J Matern Fetal Neonatal Med 2018; 31:1940.</a></li><li><a class="nounderline abstract_t">Van Mieghem T, De Heus R, Lewi L, et al. Prenatal management of monoamniotic twin pregnancies. Obstet Gynecol 2014; 124:498.</a></li><li class="breakAll">Evidence review for timing of birth: Twin and Triplet Pregnancy: Evidence review J, National Guideline Alliance (UK). (Ed), National Institute for Health and Care Excellence (NICE), London 2019.</li><li><a class="nounderline abstract_t">Vintzileos AM, Ananth CV, Kontopoulos E, Smulian JC. Mode of delivery and risk of stillbirth and infant mortality in triplet gestations: United States, 1995 through 1998. Am J Obstet Gynecol 2005; 192:464.</a></li><li><a class="nounderline abstract_t">Lappen JR, Hackney DN, Bailit JL. Maternal and neonatal outcomes of attempted vaginal compared with planned cesarean delivery in triplet gestations. Am J Obstet Gynecol 2016; 215:493.e1.</a></li><li><a class="nounderline abstract_t">Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231. Obstet Gynecol 2021; 137:e145.</a></li><li><a class="nounderline abstract_t">Francois K, Ortiz J, Harris C, et al. Is peripartum hysterectomy more common in multiple gestations? Obstet Gynecol 2005; 105:1369.</a></li><li><a class="nounderline abstract_t">Mol BW, Bergenhenegouwen L, Velzel J, et al. Perinatal outcomes according to the mode of delivery in women with a triplet pregnancy in The Netherlands. J Matern Fetal Neonatal Med 2019; 32:3771.</a></li></ol></div><div id="topicVersionRevision">Topic 6828 Version 50.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35157571" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Births: Final Data for 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24304051" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Fertility treatments and multiple births in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38175812" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : QuickStats: Rate of Triplet and Higher-Order Multiple Births,*,†by Age of Mother - National Vital Statistics System, United States, 1998 and 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9030044" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Triplet births: trends and outcomes, 1971-94.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Maternal hemodynamic changes in multiple gestation pregnancy: a longitudinal, pilot study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25223771" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Cardiovascular physiology of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12804495" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Reduction of the number of fetuses for women with triplet and higher order multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17545565" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Impact of a multiple, IVF birth on post-partum mental health: a composite analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15037391" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Parenting stress in first-time mothers of twins and triplets conceived after in vitro fertilization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15037391" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Parenting stress in first-time mothers of twins and triplets conceived after in vitro fertilization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26608832" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Perinatal and obstetric outcomes of dichorionic vs trichorionic triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26910557" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Endoscopic Placental Laser Coagulation in Dichorionic and Monochorionic Triplet Pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23200164" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Twin-twin transfusion syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37204929" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Perinatal outcome of monochorionic triamniotic triplet pregnancy: multicenter cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25060062" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Presence of an umbilical artery notch in monochorionic/monoamniotic twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8438936" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The use of color flow Doppler ultrasonography to diagnose umbilical cord entanglement in monoamniotic twin gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8843621" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : True knot of the umbilical cord: transient constrictive effect to umbilical venous blood flow demonstrated by Doppler sonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7675410" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Umbilical artery flow velocity waveforms in monoamniotic twins with cord entanglement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9586708" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Persistent abnormal umbilical cord Doppler velocimetry in a monoamniotic twin with cord entanglement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23499884" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Perinatal death of triplet pregnancies by chorionicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28264209" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Evaluation of Trichorionic versus Dichorionic Triplet Gestations from 2005 to 2016 in a Large, Referral Maternity Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24412490" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Optimal antenatal care for twin and triplet pregnancy: the evidence base.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16582114" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effect of coitus on recurrent preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16582114" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Effect of coitus on recurrent preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16238531" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Early adequate maternal weight gain is associated with fewer small for gestational age triplets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20168116" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Optimal nutrition for improved twin pregnancy outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20168116" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Optimal nutrition for improved twin pregnancy outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15098868" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Feasibility of nuchal translucency in triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18985621" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33016373" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11084544" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Chorionic villus sampling before multifetal pregnancy reduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27639267" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Glucose tolerance in singleton, twin and triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7856677" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Biophysical profile testing as an indicator of fetal well-being in high-order multiple gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27599496" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28295801" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cervical-length measurement in mid-gestation to predict spontaneous preterm birth in asymptomatic triplet pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28540576" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cervical length dynamics in triplet pregnancies: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28277920" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The role of serial measurements of cervical length in asymptomatic women with triplet pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20816146" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19155896" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25208049" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11810089" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Spontaneous reduction of multiple pregnancy: incidence and effect on outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27809628" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Preterm delivery in triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Births: Final Data for 2020</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22670489" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Births: final data for 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27167642" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prediction of Time to Delivery Week-by-Week in Women with a Triplet Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15695972" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11549860" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effect of repeated doses of dexamethasone on the incidence and severity of respiratory distress syndrome in multifetal gestation between 24 and 34 weeks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28321847" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17169012" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Magnesium sulphate given before very-preterm birth to protect infant brain: The randomised controlled PREMAG trial*.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13679932" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Risk factors for pulmonary edema in triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26383220" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A Triplet Pregnancy With Spontaneous Delivery of a Fetus at Gestational Age of 20 Weeks and Pregnancy Continuation of Two Other Fetuses Until Week 33.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12519550" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Magnesium sulphate for preventing preterm birth in threatened preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12535434" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Calcium channel blockers for inhibiting preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15495104" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Betamimetics for inhibiting preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15846626" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cyclo-oxygenase (COX) inhibitors for treating preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2648928" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Pulmonary edema associated with tocolytic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26645888" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26645888" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16157136" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Prophylactic cerclage in the management of triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33847210" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Risk of preterm birth and neonatal outcomes after cerclage placement in triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24449739" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Use of cerclage in triplet pregnancies with an asymptomatic short cervix.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19565536" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The role of ultrasound-indicated cerclage in triplets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23924878" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28262917" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26663620" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : 17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15295375" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16260508" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The effect of fetal number on the development of hypertensive conditions of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34581729" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34581729" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15692200" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Brain damage to the survivor within 30 min of co-twin demise in monochorionic twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9504230" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : What are the fetal growth patterns of singletons, twins, and triplets in the United States?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12066124" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Total and individual triplet birth weights as a function of gestational age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15467546" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Birth weight references for triplets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2406654" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Sonographic growth measurements in triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10561631" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Comprehensive fetal ultrasonographic growth measurements in triplet gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16507943" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Triplet ultrasound growth parameters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8537854" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Ultrasonographic growth measurements in triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10325293" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Comparison of fetal growth in singleton, twin, and triplet pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25431290" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Dichorionic triamniotic triplet pregnancy complicated by twin anemia polycythemia sequence: the place of fetal therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23561046" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Twin-twin transfusion syndrome and twin anemia-polycythemia sequence in a monochorionic triamniotic pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12861159" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Causes of thrombocytopenia in triplet gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9475692" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Maternal morbidity associated with triplet pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9176462" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Psychological consequences of having triplets: a 4-year follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11127031" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : [Mothers of triplets and their children: course from 4 to 7 years after birth].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12548229" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Placenta previa in singleton and twin births in the United States, 1989 through 1998: a comparison of risk factor profiles and associated conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28514884" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The association of placenta previa and assisted reproductive techniques: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25162249" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Prenatal management of monoamniotic twin pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25162249" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Prenatal management of monoamniotic twin pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15695988" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Mode of delivery and risk of stillbirth and infant mortality in triplet gestations: United States, 1995 through 1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27166014" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Maternal and neonatal outcomes of attempted vaginal compared with planned cesarean delivery in triplet gestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34011891" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15932831" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Is peripartum hysterectomy more common in multiple gestations?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29807452" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Perinatal outcomes according to the mode of delivery in women with a triplet pregnancy in The Netherlands.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
